{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:38:30Z","timestamp":1787924310197,"version":"build-2784847793"},"reference-count":217,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2015.00134","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T09:23:19Z","timestamp":1443432199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":99,"title":["Diabetes and Hepatitis C: A Two-Way Association"],"prefix":"10.3389","volume":"6","author":[{"given":"Sara Salehi","family":"Hammerstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira Frankel","family":"Grock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Hasham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"key":"B1","year":"2013","journal-title":"Hepatitis C"},{"issue":"6","key":"B2","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1002\/hep.26218","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States","volume":"57","author":"Razavi","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"B3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2003","journal-title":"Am J Med Sci"},{"issue":"12","key":"B4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cgh.2010.08.026","article-title":"Manifestations of chronic hepatitis C virus infection beyond the liver","volume":"8","author":"Jacobson","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"B5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"issue":"7","key":"B6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/ajg.2013.90","article-title":"Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy","volume":"108","author":"Montenegro","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"B7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"issue":"10","key":"B8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/j.1478-3231.2009.02095.x","article-title":"Immunogenetic susceptibility to diabetes mellitus in patients with liver disease","volume":"29","author":"Montano-Loza","year":"2009","journal-title":"Liver Int"},{"issue":"9","key":"B9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2337\/diacare.19.9.998","article-title":"High prevalence of hepatitis C virus infection in diabetic patients","volume":"19","author":"Simo","year":"1996","journal-title":"Diabetes Care"},{"issue":"4","key":"B10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1681\/ASN.V114690","article-title":"High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy","volume":"11","author":"Soma","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"B11","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1038\/srep02981","article-title":"Type 2 diabetes mellitus and the risk of hepatitis C virus infection: a systematic review","volume":"18","author":"Guo","year":"2013","journal-title":"Sci Rep"},{"issue":"3","key":"B12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1464-5491.2005.01412.x","article-title":"Hepatitis C virus infection-related type 1 diabetes mellitus","volume":"22","author":"Chen","year":"2005","journal-title":"Diabet Med"},{"issue":"3","key":"B13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.diabres.2006.07.016","article-title":"Acute onset of type 1 diabetes accompanied by acute hepatitis C: the potential role of proinflammatory cytokine in the pathogenesis of autoimmune diabetes","volume":"75","author":"Masuda","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"B14","doi-asserted-by":"publisher","first-page":"J322","DOI":"10.1016\/j.jaut.2009.11.008","article-title":"Hepatitis C and interferon induced thyroiditis","volume":"34","author":"Tomer","year":"2010","journal-title":"J Autoimmun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaut.2013.04.002","article-title":"Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways","volume":"44","author":"Hasham","year":"2013","journal-title":"J Autoimmun"},{"issue":"6","key":"B16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2036.2003.01681.x","article-title":"Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy","volume":"18","author":"Fabris","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"B17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s10067-004-1024-2","article-title":"Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C","volume":"24","author":"Niewold","year":"2005","journal-title":"Clin Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/1756-0500-6-437","article-title":"Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature","volume":"6","author":"Cacopardo","year":"2013","journal-title":"BMC Res Notes"},{"issue":"1","key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/10799900360520405","article-title":"Pernicious anemia during IFN-alpha treatment for chronic hepatitis C","volume":"23","author":"Borgia","year":"2003","journal-title":"J Interferon Cytokine Res"},{"issue":"18","key":"B20","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2169\/internalmedicine.51.7771","article-title":"New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C","volume":"51","author":"Kawazoe","year":"2012","journal-title":"Intern Med"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF02850354","article-title":"Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report","volume":"23","author":"Tomasiewicz","year":"2006","journal-title":"Adv Ther"},{"issue":"1","key":"B22","first-page":"118","article-title":"Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin","volume":"18","author":"Sykia","year":"2009","journal-title":"J Gastrointestin Liver Dis"},{"issue":"4","key":"B23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1517\/14740330903066726","article-title":"Type I IFNs and their role in the development of autoimmune diseases","volume":"8","author":"Burdick","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"B24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"key":"B25","first-page":"129","article-title":"Carbohydrate metabolism","volume-title":"Oxford Textbook of Clinical Hepatology","author":"Kruszynska","year":"1991"},{"issue":"6","key":"B26","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","article-title":"Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population","volume":"21","author":"Allison","year":"1994","journal-title":"J Hepatol"},{"issue":"3","key":"B27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/eri.09.3","article-title":"Hepatitis C and diabetes: the inevitable coincidence?","volume":"7","author":"Lonardo","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"B28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-Gomez","year":"2005","journal-title":"Gastroenterology"},{"issue":"6\u20137","key":"B29","first-page":"544","article-title":"High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study","volume":"20","author":"Grimbert","year":"1996","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"B30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"B31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4065\/75.4.355","article-title":"Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection","volume":"75","author":"Knobler","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"B32","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1111\/j.1572-0241.1998.00688.x","article-title":"HCV and diabetes mellitus: evidence for a negative association","volume":"93","author":"Mangia","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"B33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2893.2005.00677.x","article-title":"Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis","volume":"13","author":"Papatheodoridis","year":"2006","journal-title":"J Viral Hepat"},{"issue":"6","key":"B34","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1053\/j.gastro.2008.02.069","article-title":"Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors","volume":"134","author":"Missiha","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"B35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/hep.27047","article-title":"Relationship of hepatitis C virus infection with diabetes in the U.S. population","volume":"60","author":"Ruhl","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"B36","first-page":"526","article-title":"Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection","volume":"32","author":"Fraser","year":"1996","journal-title":"Isr J Med Sci"},{"issue":"6","key":"B37","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1053\/jhep.2003.09012","article-title":"Impaired IRS-1\/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"B38","first-page":"141","article-title":"Association of chronic hepatitis C infection and diabetes mellitus","volume":"19","author":"el-Zayadi","year":"1998","journal-title":"Trop Gastroenterol"},{"issue":"7","key":"B39","first-page":"1480","article-title":"Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection","volume":"91","author":"Ozyilkan","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"B40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0168-8278(00)80065-3","article-title":"Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease","volume":"32","author":"Zein","year":"2000","journal-title":"J Hepatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1743-422X-8-367","article-title":"Association of HCV with diabetes mellitus: an Egyptian case-control study","volume":"8","author":"Elhawary","year":"2011","journal-title":"Virol J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"539361","DOI":"10.1155\/2013\/539361","article-title":"Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study","volume":"2013","author":"Memon","year":"2013","journal-title":"J Diabetes Res"},{"issue":"8","key":"B43","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"issue":"4","key":"B44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00592-011-0293-x","article-title":"HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas","volume":"48","author":"Soverini","year":"2011","journal-title":"Acta Diabetol"},{"issue":"10","key":"B45","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.2337\/diacare.28.10.2548","article-title":"Hepatitis C virus infection: evidence for an association with type 2 diabetes","volume":"28","author":"Antonelli","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"B46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3904\/kjim.2001.16.1.18","article-title":"Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients","volume":"16","author":"Ryu","year":"2001","journal-title":"Korean J Intern Med"},{"issue":"4","key":"B47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s005350300063","article-title":"Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus","volume":"38","author":"Arao","year":"2003","journal-title":"J Gastroenterol"},{"issue":"4","key":"B48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S1726-4901(09)70195-9","article-title":"Seroprevalence of hepatitis B and C in type 2 diabetic patients","volume":"69","author":"Chen","year":"2006","journal-title":"J Chin Med Assoc"},{"issue":"2","key":"B49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0168-8227(99)00135-7","article-title":"Increased frequency of HCV and HBV infection in type 2 diabetic patients","volume":"48","author":"Sangiorgio","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"B50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1743-422X-7-304","article-title":"Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association","volume":"7","author":"Jadoon","year":"2010","journal-title":"Virol J"},{"issue":"4","key":"B51","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/hep.510300416","article-title":"Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection","volume":"30","author":"Caronia","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"B52","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0749-3797(02)00588-3","article-title":"Family history of diabetes as a potential public health tool","volume":"24","author":"Harrison","year":"2003","journal-title":"Am J Prev Med"},{"issue":"10","key":"B53","doi-asserted-by":"publisher","first-page":"868","DOI":"10.7326\/0003-4819-124-10-199605150-00002","article-title":"Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis interventional therapy group","volume":"124","author":"Lau","year":"1996","journal-title":"Ann Intern Med"},{"issue":"6","key":"B54","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]","volume":"125","author":"Hui","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"B55","first-page":"7","article-title":"Diabetes mellitus and cirrhosis liver","volume":"56","author":"Pazhanivel","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"4 Pt 1","key":"B56","first-page":"476","article-title":"Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis","volume":"27","author":"Custro","year":"2001","journal-title":"Diabetes Metab"},{"issue":"3","key":"B57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hep.27212","article-title":"Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study","volume":"60","author":"Huang","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"B58","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1111\/j.1572-0241.2008.02002.x","article-title":"Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study","volume":"103","author":"Giordanino","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"B59","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/hep.25867","article-title":"Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C","volume":"56","author":"Aghemo","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"B60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"B61","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1590-8658(01)80714-3","article-title":"Interactions between metabolic disorders (diabetes, gallstones, and dyslipidaemia) and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey","volume":"33","author":"Cimino","year":"2001","journal-title":"Dig Liver Dis"},{"issue":"4","key":"B62","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2337\/diacare.28.4.940","article-title":"Hepatitis C virus infection and human pancreatic beta-cell dysfunction","volume":"28","author":"Masini","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"B63","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000282103","article-title":"Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes","volume":"28","author":"Mihm","year":"2010","journal-title":"Dig Dis"},{"issue":"25","key":"B64","doi-asserted-by":"publisher","first-page":"23077","DOI":"10.1074\/jbc.M100698200","article-title":"Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase","volume":"276","author":"Bureau","year":"2001","journal-title":"J Biol Chem"},{"issue":"17","key":"B65","doi-asserted-by":"publisher","first-page":"9599","DOI":"10.1073\/pnas.171311298","article-title":"Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B","volume":"98","author":"Gong","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"45","key":"B66","doi-asserted-by":"publisher","first-page":"37481","DOI":"10.1074\/jbc.M506412200","article-title":"Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production","volume":"280","author":"Korenaga","year":"2005","journal-title":"J Biol Chem"},{"issue":"15","key":"B67","doi-asserted-by":"publisher","first-page":"7453","DOI":"10.1128\/JVI.76.15.7453-7459.2002","article-title":"Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway","volume":"76","author":"Tardif","year":"2002","journal-title":"J Virol"},{"issue":"9","key":"B68","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1365-2036.2006.03114.x","article-title":"Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin\/tumour necrosis factor-alpha in chronic hepatitis C patients","volume":"24","author":"Durante-Mangoni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"B69","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1185\/030079905X38141","article-title":"Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients","volume":"21","author":"Elsammak","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"B70","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"issue":"12","key":"B71","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.amjgastroenterol.2003.06.002","article-title":"Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association","volume":"98","author":"Knobler","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"B72","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/gut.46.2.260","article-title":"Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection","volume":"46","author":"McGuinness","year":"2000","journal-title":"Gut"},{"issue":"4","key":"B73","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1172\/JCI117495","article-title":"Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha","volume":"94","author":"Hotamisligil","year":"1994","journal-title":"J Clin Invest"},{"issue":"5091","key":"B74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"issue":"1","key":"B75","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1210\/en.130.1.43","article-title":"Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output","volume":"130","author":"Lang","year":"1992","journal-title":"Endocrinology"},{"issue":"Suppl 3","key":"B76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1365-2362.32.s3.4.x","article-title":"Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes","volume":"32","author":"Greenberg","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"B77","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNFalpha and TNF receptors in obesity and insulin resistance","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"J Intern Med"},{"issue":"11","key":"B78","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"Tumor necrosis factor alpha inhibits signaling from the insulin receptor","volume":"91","author":"Hotamisligil","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"B79","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/JVI.01672-07","article-title":"Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt\/protein kinase B signaling pathway for insulin resistance","volume":"82","author":"Banerjee","year":"2008","journal-title":"J Virol"},{"issue":"5","key":"B80","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1261\/rna.939908","article-title":"Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues","volume":"14","author":"Peltier","year":"2008","journal-title":"RNA"},{"issue":"3","key":"B81","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/15216540701313788","article-title":"Regulation of glucose transporter type 4 isoform gene expression in muscle and adipocytes","volume":"59","author":"Im","year":"2007","journal-title":"IUBMB Life"},{"issue":"5","key":"B82","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2337\/diabetes.47.5.721","article-title":"Short-term exposure to tumor necrosis factor-alpha does not affect insulin-stimulated glucose uptake in skeletal muscle","volume":"47","author":"Nolte","year":"1998","journal-title":"Diabetes"},{"issue":"1","key":"B83","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4239\/wjd.v5.i1.52","article-title":"Hepatitis C virus infection and insulin resistance","volume":"5","author":"Bose","year":"2014","journal-title":"World J Diabetes"},{"issue":"11","key":"B84","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1128\/JVI.00050-12","article-title":"Hepatitis C virus activates the mTOR\/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance","volume":"86","author":"Bose","year":"2012","journal-title":"J Virol"},{"issue":"5","key":"B85","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"issue":"5","key":"B86","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/hep.21634","article-title":"The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms","volume":"45","author":"Pazienza","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"B87","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2004.03.020","article-title":"Insulin resistance and insulin secretion in chronic hepatitis C virus infection","volume":"41","author":"Narita","year":"2004","journal-title":"J Hepatol"},{"issue":"1","key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/qjmed\/hci001","article-title":"TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad","volume":"98","author":"Knobler","year":"2005","journal-title":"QJM"},{"issue":"8","key":"B89","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/j.1478-3231.2011.02545.x","article-title":"Pegylated interferon plus ribavirin therapy improves pancreatic beta-cell function in chronic hepatitis C patients","volume":"31","author":"Huang","year":"2011","journal-title":"Liver Int"},{"issue":"3","key":"B90","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1572-0241.2006.01038.x","article-title":"Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2","volume":"102","author":"Kawaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"B91","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/diabetes.38.5.641","article-title":"Effect of interferon on glucose tolerance and insulin sensitivity","volume":"38","author":"Koivisto","year":"1989","journal-title":"Diabetes"},{"issue":"2","key":"B92","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0168-8278(99)80216-5","article-title":"Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C","volume":"31","author":"Ito","year":"1999","journal-title":"J Hepatol"},{"issue":"7","key":"B93","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2337\/dc08-2029","article-title":"Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes","volume":"32","author":"Rother","year":"2009","journal-title":"Diabetes Care"},{"issue":"12","key":"B94","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1089\/107999001317205141","article-title":"Ingested IFN-alpha preserves residual beta cell function in type 1 diabetes","volume":"21","author":"Brod","year":"2001","journal-title":"J Interferon Cytokine Res"},{"issue":"9","key":"B95","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/jmv.21269","article-title":"Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection","volume":"80","author":"Bartolome","year":"2008","journal-title":"J Med Virol"},{"issue":"6","key":"B96","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3748\/wjg.v6.i6.805","article-title":"Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C","volume":"6","author":"Yan","year":"2000","journal-title":"World J Gastroenterol"},{"issue":"6","key":"B97","doi-asserted-by":"publisher","first-page":"603","DOI":"10.6092\/1590-8577\/1948","article-title":"HBV- and HCV-related infections and risk of pancreatic cancer","volume":"14","author":"Fiorino","year":"2013","journal-title":"JOP"},{"issue":"15","key":"B98","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","article-title":"TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer","volume":"26","author":"Hussain","year":"2007","journal-title":"Oncogene"},{"issue":"6","key":"B99","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2337\/diacare.20.6.1044a","article-title":"Antibodies to GAD in chronic hepatitis C patients","volume":"20","author":"Hieronimus","year":"1997","journal-title":"Diabetes Care"},{"issue":"9","key":"B100","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/(SICI)1096-9136(199809)15:9797::AID-DIA6753.3.CO;2-D","article-title":"Antibodies to GAD in diabetic patients with chronic hepatitis C","volume":"15","author":"Ando","year":"1998","journal-title":"Diabet Med"},{"issue":"1","key":"B101","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1067\/mlc.2001.111515","article-title":"Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon","volume":"137","author":"Piquer","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"927","key":"B102","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"22","key":"B103","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","article-title":"Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis interventional therapy group","volume":"321","author":"Davis","year":"1989","journal-title":"N Engl J Med"},{"issue":"8818","key":"B104","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","article-title":"Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis","volume":"340","author":"Fabris","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"B105","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J Hepatol"},{"issue":"2","key":"B106","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2337\/dc10-1237","article-title":"Clinical and genetic characteristics of patients with type 1 diabetes associated with interferon therapy","volume":"34","author":"Nakanishi","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"B107","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high-dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J Hepatol"},{"issue":"9","key":"B108","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2337\/dc10-2274","article-title":"Type 1 diabetes and interferon therapy: a nationwide survey in Japan","volume":"34","author":"Nakamura","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"B109","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1478-3231.2007.01610.x","article-title":"High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection","volume":"28","author":"Schreuder","year":"2008","journal-title":"Liver Int"},{"key":"B110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/CMED.S7815","article-title":"Type 1 diabetes mellitus associated with pegylated interferon-alpha plus ribavirin treatment for chronic hepatitis C: case report and literature review","volume":"4","author":"Oka","year":"2011","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"13","key":"B111","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"B112","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/MPG.0b013e3182774cae","article-title":"Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C","volume":"56","author":"Molleston","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"B113","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s00535-012-0631-y","article-title":"Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C","volume":"48","author":"Minami","year":"2013","journal-title":"J Gastroenterol"},{"issue":"3","key":"B114","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/gut.48.3.378","article-title":"Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C","volume":"48","author":"Wesche","year":"2001","journal-title":"Gut"},{"issue":"4","key":"B115","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ecl.2007.07.001","article-title":"Interferon alpha treatment and thyroid dysfunction","volume":"36","author":"Tomer","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8829","key":"B116","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/0140-6736(92)92944-B","article-title":"Interferon alfa and development of type 1 diabetes mellitus","volume":"340","author":"Koivisto","year":"1992","journal-title":"Lancet"},{"issue":"6","key":"B117","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1073\/pnas.88.6.2451","article-title":"Genetic organization and diversity of the hepatitis C virus","volume":"88","author":"Choo","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"B118","doi-asserted-by":"publisher","first-page":"634","DOI":"10.7326\/0003-4819-125-8-199610150-00002","article-title":"Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative study group","volume":"125","author":"Zein","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"B119","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0168-8278(05)80205-3","article-title":"Differences in the hepatitis C virus genotypes in different countries","volume":"17","author":"Takada","year":"1993","journal-title":"J Hepatol"},{"issue":"3","key":"B120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1440-1746.1996.tb00063.x","article-title":"Distribution of the different subtypes of hepatitis C virus in Japan and the effects of interferon: a nationwide survey","volume":"11","author":"Takada","year":"1996","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"B121","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/CMR.13.2.223-235.2000","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"13","author":"Zein","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"B122","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1751-2980.2012.00636.x","article-title":"Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients\u2019 characteristics and clinical parameters","volume":"13","author":"Dong","year":"2012","journal-title":"J Dig Dis"},{"issue":"1\u20133","key":"B123","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12026-012-8302-x","article-title":"Genetic and epigenetic mechanisms in thyroid autoimmunity","volume":"54","author":"Hasham","year":"2012","journal-title":"Immunol Res"},{"issue":"2","key":"B124","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"55","author":"European Association for the Study of the Liver","year":"2011","journal-title":"J Hepatol"},{"issue":"3","key":"B125","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1478-3231.2009.02188.x","article-title":"The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report","volume":"30","author":"Antaki","year":"2010","journal-title":"Liver Int"},{"issue":"16","key":"B126","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2169\/internalmedicine.48.2220","article-title":"Peginterferon (PEG-IFN) plus ribavirin combination therapy, but neither interferon nor PGE-IFN alone, induced type 1 diabetes in a patient with chronic hepatitis C","volume":"48","author":"Ogihara","year":"2009","journal-title":"Intern Med"},{"issue":"2","key":"B127","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"60","author":"European Association for Study of Liver","year":"2014","journal-title":"J Hepatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"bcr2013200514","DOI":"10.1136\/bcr-2013-200514","article-title":"Chronic hepatitis C therapy: a rare complication revisited","volume":"2013","author":"Alsabbagh","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"6","key":"B129","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/er.2008-0015","article-title":"Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms","volume":"29","author":"Huber","year":"2008","journal-title":"Endocr Rev"},{"issue":"10","key":"B130","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1210\/jcem.84.10.6045","article-title":"Human leukocyte antigen-A24 and -DQA1*0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction","volume":"84","author":"Nakanishi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"B131","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0168-8278(99)80131-7","article-title":"HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C","volume":"30","author":"Kakizaki","year":"1999","journal-title":"J Hepatol"},{"issue":"2\u20134","key":"B132","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/10446670310001642177","article-title":"The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse","volume":"10","author":"Oppenheim","year":"2003","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"B133","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.4049\/jimmunol.160.6.2742","article-title":"Induction of Jak\/STAT signaling by activation of the type 1 TNF receptor","volume":"160","author":"Guo","year":"1998","journal-title":"J Immunol"},{"issue":"1 Suppl 1","key":"B134","first-page":"14","article-title":"Signal transduction in the interferon system","volume":"25","author":"Haque","year":"1998","journal-title":"Semin Oncol"},{"issue":"5589","key":"B135","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1126\/science.1074900","article-title":"Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection","volume":"297","author":"Nguyen","year":"2002","journal-title":"Science"},{"issue":"8573","key":"B136","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(87)91128-7","article-title":"Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus","volume":"2","author":"Foulis","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"B137","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.153.3.1360","article-title":"Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile","volume":"153","author":"Somoza","year":"1994","journal-title":"J Immunol"},{"issue":"6","key":"B138","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2337\/diab.44.6.658","article-title":"Interferon expression in the pancreases of patients with type I diabetes","volume":"44","author":"Huang","year":"1995","journal-title":"Diabetes"},{"issue":"5116","key":"B139","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1126\/science.8100367","article-title":"Induction of type I diabetes by interferon-alpha in transgenic mice","volume":"260","author":"Stewart","year":"1993","journal-title":"Science"},{"issue":"8","key":"B140","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.4049\/jimmunol.1002631","article-title":"IFN-alpha mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms","volume":"186","author":"Akeno","year":"2011","journal-title":"J Immunol"},{"issue":"34","key":"B141","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.1073\/pnas.0806439105","article-title":"Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"B142","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/jaut.2001.0531","article-title":"Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1","volume":"17","author":"Nakazawa","year":"2001","journal-title":"J Autoimmun"},{"issue":"12","key":"B143","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res"},{"issue":"7","key":"B144","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2337\/diab.38.7.815","article-title":"MHC molecules and beta-cell destruction. Immune and nonimmune mechanisms","volume":"38","author":"Harrison","year":"1989","journal-title":"Diabetes"},{"issue":"5","key":"B145","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20131556","article-title":"Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection","volume":"211","author":"Srivastava","year":"2014","journal-title":"J Exp Med"},{"issue":"7","key":"B146","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10585-012-9504-2","article-title":"Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients","volume":"29","author":"Mozzillo","year":"2012","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"B147","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s10753-013-9677-0","article-title":"CD4+CD25+Foxp3+ regulatory T cells contribute in liver fibrosis improvement with interferon alpha","volume":"36","author":"Feng","year":"2013","journal-title":"Inflammation"},{"issue":"5","key":"B148","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jhep.2010.04.035","article-title":"Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis","volume":"53","author":"Nkontchou","year":"2010","journal-title":"J Hepatol"},{"issue":"9055","key":"B149","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"B150","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"8","key":"B151","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1046\/j.1440-1746.2002.02813.x","article-title":"Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection","volume":"17","author":"Hui","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"B152","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1440-1746.2009.06186.x","article-title":"Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection","volume":"25","author":"Hsu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"B153","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/gut.2006.107946","article-title":"Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease","volume":"56","author":"Svegliati-Baroni","year":"2007","journal-title":"Gut"},{"issue":"12","key":"B154","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1136\/gut.2009.179085","article-title":"Insulin resistance is associated with liver stiffness in HIV\/HCV co-infected patients","volume":"58","author":"Merchante","year":"2009","journal-title":"Gut"},{"issue":"12","key":"B155","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s10620-008-0683-2","article-title":"Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection","volume":"54","author":"Elgouhari","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"4","key":"B156","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jhep.2008.12.017","article-title":"Insulin resistance predicts response to peginterferon-alpha\/ribavirin combination therapy in chronic hepatitis C patients","volume":"50","author":"Dai","year":"2009","journal-title":"J Hepatol"},{"issue":"6","key":"B157","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/hep.23206","article-title":"Treatment of insulin resistance with metformin in naive genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin","volume":"50","author":"Romero-Gomez","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"B158","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1478-3231.2010.02343.x","article-title":"The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients","volume":"31","author":"Fattovich","year":"2011","journal-title":"Liver Int"},{"issue":"6","key":"B159","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jhep.2011.03.010","article-title":"Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis","volume":"55","author":"Deltenre","year":"2011","journal-title":"J Hepatol"},{"key":"B160","year":"2008","journal-title":"World Cancer Report 2008 [Article Online]"},{"issue":"1","key":"B161","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ajg.2011.384","article-title":"Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study","volume":"107","author":"Lai","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"B162","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/hep.22251","article-title":"Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus","volume":"47","author":"Veldt","year":"2008","journal-title":"Hepatology"},{"issue":"9","key":"B163","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"B164","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence","volume":"4","author":"El-Serag","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"B165","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"issue":"4 Pt 1","key":"B166","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"B167","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2010.06.021","article-title":"Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C","volume":"54","author":"Garcia-Monzon","year":"2011","journal-title":"J Hepatol"},{"issue":"23","key":"B168","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","article-title":"Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen","volume":"20","author":"Lonardo","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6 Pt 2","key":"B169","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1262-3636(08)74600-7","article-title":"Insulin resistance and steatosis in humans","volume":"34","author":"Capeau","year":"2008","journal-title":"Diabetes Metab"},{"issue":"9","key":"B170","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.2337\/db12-1122","article-title":"Relation between serum free fatty acids and adiposity, insulin resistance, and cardiovascular risk factors from adolescence to adulthood","volume":"62","author":"Frohnert","year":"2013","journal-title":"Diabetes"},{"issue":"7","key":"B171","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"Fartoux","year":"2005","journal-title":"Gut"},{"issue":"5","key":"B172","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jhep.2013.06.025","article-title":"The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-beta signaling","volume":"59","author":"Goto","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"B173","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000282104","article-title":"Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management","volume":"28","author":"del Campo","year":"2010","journal-title":"Dig Dis"},{"issue":"23","key":"B174","doi-asserted-by":"publisher","first-page":"19564","DOI":"10.1074\/jbc.M112.342709","article-title":"Protein-tyrosine phosphatases are involved in interferon resistance associated with insulin resistance in HepG2 cells and obese mice","volume":"287","author":"Garcia-Ruiz","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"B175","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/hep.24394","article-title":"Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: a vicious circle of clinical significance?","volume":"54","author":"Franceschini","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"B176","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4161\/auto.22791","article-title":"Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy","volume":"9","author":"Huang","year":"2013","journal-title":"Autophagy"},{"issue":"6","key":"B177","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1016\/j.ijid.2012.02.004","article-title":"The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance","volume":"16","author":"Yu","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"1","key":"B178","first-page":"13","article-title":"Efficacy of adding metformin to pegylated interferon and ribavirin in treatment naive patients with chronic hepatitis C: a randomized double-blind controlled trial","volume":"6","author":"Sharifi","year":"2014","journal-title":"Middle East J Dig Dis"},{"issue":"16","key":"B179","doi-asserted-by":"publisher","first-page":"11836","DOI":"10.1074\/jbc.M610106200","article-title":"p21-activated kinase 1 is activated through the mammalian target of rapamycin\/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells","volume":"282","author":"Ishida","year":"2007","journal-title":"J Biol Chem"},{"issue":"35","key":"B180","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.3748\/wjg.15.4356","article-title":"Molecular mechanisms of insulin resistance in chronic hepatitis C","volume":"15","author":"Douglas","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"2","key":"B181","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"B182","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1046\/j.1365-2893.2003.00387.x","article-title":"The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C","volume":"10","author":"Myers","year":"2003","journal-title":"J Viral Hepat"},{"issue":"7","key":"B183","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"B184","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ecl.2013.09.008","article-title":"Diabetes and cancer","volume":"43","author":"Zelenko","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"B185","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jdiacomp.2010.06.004","article-title":"Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan","volume":"24","author":"Noto","year":"2010","journal-title":"J Diabetes Complications"},{"key":"B186","first-page":"53","article-title":"Chapter 2 insulin\/IGF-1 signaling nodes and their role in carcinogenesis","volume-title":"Energy Balance and Cancer","author":"Taniguchi","year":"2011"},{"issue":"13","key":"B187","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-12-3824","article-title":"Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors","volume":"73","author":"Chettouh","year":"2013","journal-title":"Cancer Res"},{"issue":"5","key":"B188","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/01.med.0000433065.16918.83","article-title":"Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?","volume":"20","author":"Gallagher","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B189","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/B978-0-12-416673-8.00010-1","article-title":"The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer","volume":"93","author":"Ferguson","year":"2013","journal-title":"Vitam Horm"},{"issue":"3","key":"B190","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1210\/jcem.79.3.7521354","article-title":"Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes","volume":"79","author":"Brismar","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"B191","first-page":"1030","article-title":"Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis","volume":"62","author":"Wu","year":"2002","journal-title":"Cancer Res"},{"issue":"22","key":"B192","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1002\/cncr.28832","article-title":"Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model","volume":"120","author":"Flemming","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"B193","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/hep.23892","article-title":"Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis","volume":"52","author":"Sharma","year":"2010","journal-title":"Hepatology"},{"issue":"46","key":"B194","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.3748\/wjg.v16.i46.5801","article-title":"Leptin in hepatocellular carcinoma","volume":"16","author":"Wang","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"9","key":"B195","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov"},{"issue":"3","key":"B196","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"B197","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/apt.12149","article-title":"Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program","volume":"37","author":"Armstrong","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"B198","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","article-title":"Standards of medical care in diabetes \u2013 2014","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"issue":"10","key":"B199","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jcma.2012.07.008","article-title":"Combination effect of ribavirin and erythropoietin treatment on hemoglobin A1c in a diabetic patient with chronic hepatitis C","volume":"75","author":"Tai","year":"2012","journal-title":"J Chin Med Assoc"},{"issue":"8","key":"B200","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1210\/jc.2010-2415","article-title":"Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients","volume":"96","author":"Nkontchou","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"B201","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1331\/JAPhA.2010.08090","article-title":"Clarifying metformin\u2019s role and risks in liver dysfunction","volume":"50","author":"Brackett","year":"2010","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"B202","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"B203","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1756283X11403809","article-title":"The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis","volume":"4","author":"Van Wagner","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"B204","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/mco.2014.435","article-title":"Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: a prospective study","volume":"3","author":"Sumie","year":"2015","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"B205","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7326\/0003-4819-132-2-200001180-00006","article-title":"Hepatocellular injury in a patient receiving rosiglitazone. A case report","volume":"132","author":"Al-Salman","year":"2000","journal-title":"Ann Intern Med"},{"issue":"7","key":"B206","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1023\/A:1015895925374","article-title":"Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone","volume":"47","author":"Bonkovsky","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"2","key":"B207","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1542-3565(04)00667-6","article-title":"A randomized controlled trial of acarbose in hepatic encephalopathy","volume":"3","author":"Gentile","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"B208","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/BF02936954","article-title":"Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose","volume":"32","author":"Kihara","year":"1997","journal-title":"J Gastroenterol"},{"issue":"2","key":"B209","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-2002-30102","article-title":"Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs","volume":"22","author":"Chitturi","year":"2002","journal-title":"Semin Liver Dis"},{"issue":"2","key":"B210","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1440-1746.2007.05183.x","article-title":"Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance","volume":"23","author":"Itou","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"B211","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/dmrr.2580","article-title":"GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease","volume":"31","author":"Liu","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"issue":"23","key":"B212","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.3748\/wjg.v20.i23.7356","article-title":"Incretin based therapies: a novel treatment approach for non-alcoholic fatty liver disease","volume":"20","author":"Blaslov","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"B213","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1872-034X.2011.00798.x","article-title":"Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus","volume":"41","author":"Arase","year":"2011","journal-title":"Hepatol Res"},{"issue":"3","key":"B214","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1478-3231.2009.02191.x","article-title":"Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection","volume":"30","author":"Kawaguchi","year":"2010","journal-title":"Liver Int"},{"issue":"5","key":"B215","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease","volume":"30","author":"Donadon","year":"2010","journal-title":"Liver Int"},{"issue":"20","key":"B216","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3748\/wjg.15.2506","article-title":"Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease","volume":"15","author":"Donadon","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"6","key":"B217","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ajg.2013.5","article-title":"Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T17:14:43Z","timestamp":1692033283000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fendo.2015.00134\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":217,"URL":"https:\/\/doi.org\/10.3389\/fendo.2015.00134","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]}}}